Impact of motion management strategies on abdominal organ at risk delineation for magnetic resonance-guided radiotherapy

被引:0
|
作者
Daly, Mairead [1 ]
McDaid, Lisa [2 ]
Anandadas, Carmel [3 ]
Brocklehurst, Andrew [3 ]
Choudhury, Ananya [1 ,3 ]
McWilliam, Alan [1 ,4 ]
Radhakrishna, Ganesh [1 ,3 ]
Eccles, Cynthia L. [1 ,2 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Manchester M13 9PL, England
[2] Christie NHS Fdn Trust, Dept Radiotherapy, Manchester M20 4BX, England
[3] Christie Hosp NHS Fdn Trust, Dept Clin Oncol, Manchester M20 4BX, England
[4] Christie Hosp NHS Fdn Trust, Dept Med Phys & Engn, Manchester M20 4BX, England
关键词
Motion management; MR-guided radiotherapy; SABR; SBRT; IGRT; INTEROBSERVER VARIABILITY; VOLUME DELINEATION; MRI; SEGMENTATION; CANCER;
D O I
10.1016/j.phro.2024.100650
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: The impact of respiratory motion management strategies for abdominal radiotherapy, such as abdominal compression (AC) and breath hold (BH), on abdominal organ at risk (OAR) delineation on magnetic resonance imaging (MRI) is unknown. This feasibility study compared the inter- and intra- observer delineation variation on MRI acquired with AC, BH for three critical abdominal OAR. Materials and methods: T2-weighted (W) 3D MRI in free-breathing (FB) and with AC, and T1W 3D mDixon exhale BH were acquired. Four observers blinded to motion management strategy used, delineated stomach, liver, and duodenum on all MRI. One case per strategy was repeated over 6 weeks later to quantify intra-observer variation. Simultaneous truth and performance level estimation (STAPLE) contours for each OAR were generated, median and IQR mean distance to agreement (mDTA) and maximum Hausdorff distance (HD) between observer and STAPLE contours were calculated. Observers scored organ visibility on each MRI using a four-point Likert scale. Results: A total of 27 scans including repeats were delineated. Pooled mDTA for all OARs was 1.3 mm (0.5 mm) with AC, 1.4 mm (1.0 mm) with BH, and 1.3 mm (0.5 mm) in FB. Intra-observer mDTA was highest for all organs in FB with 10.8 mm for duodenum, 1.8 mm for liver, and 2.7 mm for stomach. The pooled mean perceptual quality score value was highest for AC across organs. Conclusions: No motion management strategy demonstrated superior similarity across OAR, emphasizing the need for personalised approaches based on individual clinical and patient factors.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced: the PUMA trial
    Regnery, Sebastian
    de Colle, Chiara
    Eze, Chukwuka
    Corradini, Stefanie
    Thieke, Christian
    Sedlaczek, Oliver
    Schlemmer, Heinz-Peter
    Dinkel, Julien
    Seith, Ferdinand
    Kopp-Schneider, Annette
    Gillmann, Clarissa
    Renkamp, C. Katharina
    Landry, Guillaume
    Thorwarth, Daniela
    Zips, Daniel
    Belka, Claus
    Jaekel, Oliver
    Debus, Juergen
    Hoerner-Rieber, Juliane
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [32] First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience
    Sahin, Bilgehan
    Mustafayev, Teuta Zoto
    Gungor, Gorkem
    Aydin, Gokhan
    Yapici, Bulent
    Atalar, Banu
    Ozyar, Enis
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (12)
  • [33] Deep learning-based dose prediction for magnetic resonance-guided prostate radiotherapy
    Fransson, Samuel
    Strand, Robin
    Tilly, David
    MEDICAL PHYSICS, 2024,
  • [34] Synthetic computed tomography for low-field magnetic resonance-guided radiotherapy in the abdomen
    Lapaeva, Mariia
    Saint-Esteven, Agustina La Greca
    Wallimann, Philipp
    Guenther, Manuel
    Konukoglu, Ender
    Andratschke, Nicolaus
    Guckenberger, Matthias
    Tanadini-Lang, Stephanie
    Dal Bello, Riccardo
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2022, 24 : 173 - 179
  • [35] MAGELLAN: Magnetic Resonance-guided adaptive stereotactic Radiotherapy of Lung Tumors in ultracentral Location
    Regnery, S.
    Weykamp, F.
    Hoegen, P.
    Sprengel, S.
    Eichkorn, T.
    Buchele, C.
    Paul, K.
    Klueter, S.
    Pohl, M.
    Meis, J.
    Koenig, L.
    Adeberg, S.
    Koerber, S.
    Debus, J.
    Hoerner-Rieber, J.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S178 - S178
  • [36] An Essential Treatment Pattern of Lung Cancer: Magnetic Resonance-Guided Stereotactic Body Radiotherapy
    Wang, X.
    Li, Z.
    Yin, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E567 - E567
  • [37] Stereotactic radiotherapy and the potential role of magnetic resonance-guided adaptive techniques for pancreatic cancer
    Tai Ermongkonchai
    Richard Khor
    Vijayaragavan Muralidharan
    Niall Tebbutt
    Kelvin Lim
    Numan Kutaiba
    Sweet Ping Ng
    World Journal of Gastroenterology, 2022, (07) : 745 - 754
  • [38] Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
    Weykamp, Fabian
    Katsigiannopulos, Efthimios
    Piskorski, Lars
    Regnery, Sebastian
    Hoegen, Philipp
    Ristau, Jonas
    Renkamp, C. Katharina
    Liermann, Jakob
    Forster, Tobias
    Lang, Kristin
    Koenig, Laila
    Rippke, Carolin
    Buchele, Carolin
    Debus, Juergen
    Klueter, Sebastian
    Hoerner-Rieber, Juliane
    CANCERS, 2022, 14 (24)
  • [39] Clinical and economic impact of cardiac magnetic resonance-guided decision-making
    Tundidor Sanz, Maria Elena
    Barreiro Perez, Manuel
    Luengo Mondejar, Pablo
    Garcia Sanchez, Maria Jesus
    Fernandez-Vazquez, Felipe
    Sanchez Fernandez, Pedro L.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2022, 75 (07): : 610 - 611
  • [40] MAGNETIC RESONANCE-GUIDED ADAPTIVE RADIOTHERAPY REDUCES THE NORMAL TISSUE COMPLICATION PROBABILITY OF ADRENAL STEREOTACTIC ABLATIVE RADIOTHERAPY
    Chen, Hanbo
    de Koste, John van Sornsen
    Bohoudi, Omar
    Slotman, Ben
    Palacios, Miguel
    Senan, Suresh
    Lagerwaard, Frank
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S82 - S82